Comments
Loading...
Tyra Biosciences Analyst Ratings and Price Targets | NASDAQ:TYRA | Benzinga
Tyra Biosciences Inc has a consensus price target of $27.86 based on the ratings of 7 analysts. The high is $33 issued by Oppenheimer on September 19, 2024. The low is $12 issued by HC Wainwright & Co. on June 23, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 31, 2025, February 18, 2025, and January 13, 2025, respectively. With an average price target of $30 between HC Wainwright & Co., there's an implied 189.30% upside for Tyra Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
UBS
Wedbush
B of A Securities
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Tyra Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/31/2025 | Buy Now | 189.3% | HC Wainwright & Co. | Mitchell Kapoor46% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/18/2025 | Buy Now | 189.3% | HC Wainwright & Co. | Mitchell Kapoor46% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 189.3% | HC Wainwright & Co. | Mitchell Kapoor46% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/07/2025 | Buy Now | 170.01% | UBS | Eliana Merle43% | → $28 | Initiates | → Buy | Get Alert |
| 11/11/2024 | Buy Now | 189.3% | HC Wainwright & Co. | Mitchell Kapoor46% | $32 → $30 | Maintains | Buy | Get Alert |
| 10/29/2024 | Buy Now | 208.58% | HC Wainwright & Co. | Mitchell Kapoor46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 10/28/2024 | Buy Now | 208.58% | HC Wainwright & Co. | Mitchell Kapoor46% | $30 → $32 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 170.01% | Wedbush | Robert Driscoll44% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 10/18/2024 | Buy Now | 198.94% | B of A Securities | Geoff Meacham62% | $22 → $31 | Upgrade | Neutral → Buy | Get Alert |
| 10/07/2024 | Buy Now | 189.3% | HC Wainwright & Co. | Mitchell Kapoor46% | $25 → $30 | Maintains | Buy | Get Alert |
| 09/19/2024 | Buy Now | 218.23% | Oppenheimer | Matthew Biegler37% | $25 → $33 | Maintains | Outperform | Get Alert |
| 08/15/2024 | Buy Now | 218.23% | Piper Sandler | Christopher Raymond55% | → $33 | Initiates | → Overweight | Get Alert |
| 08/08/2024 | Buy Now | 170.01% | Wedbush | Robert Driscoll44% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2024 | Buy Now | 141.08% | Oppenheimer | Matthew Biegler37% | $28 → $25 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | 170.01% | Oppenheimer | Matthew Biegler37% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 07/03/2024 | Buy Now | 170.01% | Wedbush | Robert Driscoll44% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 07/03/2024 | Buy Now | 121.79% | HC Wainwright & Co. | Mitchell Kapoor46% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 121.79% | HC Wainwright & Co. | Mitchell Kapoor46% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 170.01% | Oppenheimer | Matthew Biegler37% | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | 170.01% | Wedbush | Robert Driscoll44% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | 121.79% | HC Wainwright & Co. | Mitchell Kapoor46% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 170.01% | Wedbush | Robert Driscoll44% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | Buy Now | 121.79% | HC Wainwright & Co. | Mitchell Kapoor46% | $19 → $23 | Reiterates | Buy → Buy | Get Alert |
| 12/29/2023 | Buy Now | 160.37% | Wedbush | Robert Driscoll44% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 12/26/2023 | Buy Now | 83.22% | HC Wainwright & Co. | Mitchell Kapoor46% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2023 | Buy Now | 83.22% | HC Wainwright & Co. | Mitchell Kapoor46% | $20 → $19 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 160.37% | Wedbush | Robert Driscoll44% | → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | Buy Now | 92.86% | HC Wainwright & Co. | Mitchell Kapoor46% | $17 → $20 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 63.93% | HC Wainwright & Co. | Mitchell Kapoor46% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 160.37% | Wedbush | Robert Driscoll44% | → $27 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 141.08% | Oppenheimer | Matthew Biegler37% | → $25 | Reiterates | → Outperform | Get Alert |
| 05/05/2023 | Buy Now | 63.93% | HC Wainwright & Co. | Mitchell Kapoor46% | → $17 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 63.93% | HC Wainwright & Co. | Mitchell Kapoor46% | → $17 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | Buy Now | 63.93% | HC Wainwright & Co. | Mitchell Kapoor46% | $15 → $17 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | 44.65% | HC Wainwright & Co. | Mitchell Kapoor46% | $12 → $15 | Maintains | Buy | Get Alert |
| 02/03/2023 | Buy Now | 63.93% | Oppenheimer | Matthew Biegler37% | → $17 | Initiates | → Outperform | Get Alert |
| 06/23/2022 | Buy Now | 15.72% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $12 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Tyra Biosciences (TYRA) stock?
The latest price target for Tyra Biosciences (NASDAQ:TYRA) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $30.00 expecting TYRA to rise to within 12 months (a possible 189.30% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tyra Biosciences (TYRA)?
The latest analyst rating for Tyra Biosciences (NASDAQ:TYRA) was provided by HC Wainwright & Co., and Tyra Biosciences reiterated their buy rating.
When was the last upgrade for Tyra Biosciences (TYRA)?
The last upgrade for Tyra Biosciences Inc happened on October 18, 2024 when B of A Securities raised their price target to $31. B of A Securities previously had a neutral for Tyra Biosciences Inc.
When was the last downgrade for Tyra Biosciences (TYRA)?
There is no last downgrade for Tyra Biosciences.
When is the next analyst rating going to be posted or updated for Tyra Biosciences (TYRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tyra Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tyra Biosciences was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.
Is the Analyst Rating Tyra Biosciences (TYRA) correct?
While ratings are subjective and will change, the latest Tyra Biosciences (TYRA) rating was a reiterated with a price target of $30.00 to $30.00. The current price Tyra Biosciences (TYRA) is trading at is $10.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
